S. Amberg

发表

A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

M. Heuser, F. Thol, A. Ganser, 2020, British journal of haematology.

Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL.

C. Bokemeyer, J. Mann, A. Stein, 2020, Current cancer drug targets.

A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation.

Martijn P. D. Haring, S. von Felten, N. Heaton, 2023, Journal of hepatology.